ID: ALA555505
Chembl Id: CHEMBL555505
PubChem CID: 45265336
Max Phase: Preclinical
Molecular Formula: C11H12Cl2N2O
Molecular Weight: 222.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Clc1cccc2c1OC(C1=NCCN1)C2
Standard InChI: InChI=1S/C11H11ClN2O.ClH/c12-8-3-1-2-7-6-9(15-10(7)8)11-13-4-5-14-11;/h1-3,9H,4-6H2,(H,13,14);1H
Standard InChI Key: AJOXZPILAFOAOE-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 222.68 | Molecular Weight (Monoisotopic): 222.0560 | AlogP: 1.65 | #Rotatable Bonds: 1 |
| Polar Surface Area: 33.62 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 9.10 | CX LogP: 1.74 | CX LogD: 0.11 |
| Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.78 | Np Likeness Score: -0.08 |
| 1. Chapleo CB, Myers PL, Butler RC, Davis JA, Doxey JC, Higgins SD, Myers M, Roach AG, Smith CF, Stillings MR.. (1984) Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity., 27 (5): [PMID:6143826] [10.1021/jm00371a003] |
Source(1):
